Summit Toxicology
Private Company
Total funding raised: $4M
Overview
Summit Toxicology is a long-established, privately-held consulting firm specializing in applied toxicology and human health risk assessment. The company leverages deep scientific expertise in pharmacokinetic modeling, dose-response analysis, and regulatory science to support clients in the chemical, pharmaceutical, and government sectors. With a principal-led structure and a geographically distributed team, it operates as a high-level scientific advisory and litigation support service. Its business model is entirely service-based, generating revenue through client consulting projects rather than product development.
Technology Platform
Methodological expertise in quantitative toxicology, including Physiologically Based Pharmacokinetic (PBPK) Modeling, Benchmark Dose (BMD) Modeling, Monte Carlo simulation, and biomonitoring equivalent (BE) derivation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with the risk assessment divisions of large Contract Research Organizations (CROs), other boutique toxicology consultancies, and independent academic experts. Differentiation is based on deep methodological expertise in advanced modeling, the publication records of its principals, and its long-standing reputation.